Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1

被引:97
作者
Kazzaz, J [1 ]
Neidleman, J [1 ]
Singh, M [1 ]
Ott, G [1 ]
O'Hagan, DT [1 ]
机构
[1] Chiron Corp, Emeryville, CA 94608 USA
关键词
microparticles; adjuvant; vaccine; HIV-1; cytotoxic T lymphocytes;
D O I
10.1016/S0168-3659(00)00226-1
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Microparticles with entrapped antigens have recently been shown to possess significant potential as vaccine delivery systems and adjuvants. However, the potential of microparticles as adjuvants has been seriously limited by the common problem of degradation and denaturation of antigens following encapsulation and release. To overcome these problems, we have developed a novel way to use microparticles as adjuvants, by the adsorption of proteins onto their surface. Anionic microparticles were prepared through the inclusion of an anionic detergent, sodium dodecyl sulphate (SDS), in the microparticle preparation process. The anionic microparticles were capable of the efficient and reproducible adsorption of recombinant p55 gag protein from HIV-1. Microparticles with adsorbed p55 were capable of inducing potent cytotoxic T lymphocyte responses in mice following intramuscular immunization. In addition, the microparticles also exhibited a potent adjuvant effect for antibody induction against p55. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:347 / 356
页数:10
相关论文
共 30 条
[1]   Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques [J].
Baba, TW ;
Liska, V ;
Khimani, AH ;
Ray, NB ;
Dailey, PJ ;
Penninck, D ;
Bronson, R ;
Greene, MF ;
McClure, HM ;
Martin, LN ;
Ruprecht, RM .
NATURE MEDICINE, 1999, 5 (02) :194-203
[2]   VIRUS-SPECIFIC CD8+ CYTOTOXIC T-LYMPHOCYTE ACTIVITY ASSOCIATED WITH CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
BORROW, P ;
LEWICKI, H ;
HAHN, BH ;
SHAW, GM ;
OLDSTONE, MBA .
JOURNAL OF VIROLOGY, 1994, 68 (09) :6103-6110
[3]   In vivo migration and function of transferred HIV-1-specific cytotoxic T cells [J].
Brodie, SJ ;
Lewinsohn, DA ;
Patterson, BK ;
Jiyamapa, D ;
Krieger, J ;
Corey, L ;
Greenberg, PD ;
Riddell, SR .
NATURE MEDICINE, 1999, 5 (01) :34-41
[4]   CONTROLLED RELEASE OF INSULIN FROM POLYMER MATRICES - CONTROL OF DIABETES IN RATS [J].
BROWN, L ;
MUNOZ, C ;
SIEMER, L ;
EDELMAN, E ;
LANGER, R .
DIABETES, 1986, 35 (06) :692-697
[5]   INDUCTION OF HIV-1 ENVELOPE (GP120)-SPECIFIC CYTOTOXIC T-LYMPHOCYTE RESPONSES IN MICE BY RECOMBINANT CHO CELL-DERIVED GP120 IS ENHANCED BY ENZYMATIC REMOVAL OF N-LINKED GLYCANS [J].
DOE, B ;
STEIMER, KS ;
WALKER, CM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (10) :2369-2376
[6]   BIODEGRADABLE AND BIOCOMPATIBLE POLY(DL-LACTIDE-CO-GLYCOLIDE) MICROSPHERES AS AN ADJUVANT FOR STAPHYLOCOCCAL ENTEROTOXIN-B TOXOID WHICH ENHANCES THE LEVEL OF TOXIN-NEUTRALIZING ANTIBODIES [J].
ELDRIDGE, JH ;
STAAS, JK ;
MEULBROEK, JA ;
TICE, TR ;
GILLEY, RM .
INFECTION AND IMMUNITY, 1991, 59 (09) :2978-2986
[7]  
Gupta R K, 1995, Pharm Biotechnol, V6, P229
[8]   ADJUVANTS FOR HUMAN VACCINES - CURRENT STATUS, PROBLEMS AND FUTURE-PROSPECTS [J].
GUPTA, RK ;
SIBER, GR .
VACCINE, 1995, 13 (14) :1263-1276
[9]   A simplified vaccinologists' vaccinology and the pursuit of a vaccine against AIDS [J].
Hilleman, MR .
VACCINE, 1998, 16 (08) :778-793
[10]   Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma [J].
Igarashi, T ;
Brown, C ;
Azadegan, A ;
Haigwood, N ;
Dimitrov, D ;
Martin, MA ;
Shibata, R .
NATURE MEDICINE, 1999, 5 (02) :211-216